MKI67 and neoplasm: Furthermore, immunohistochemistry analysis of CDC27 and a proliferation marker, Ki67, was conducted and measured in tumor xenograft tissues (Figure 6C–6F), which revealed significantly higher levels of CDC27, but lower levels of Ki67, in the mir-218-2-inhibited group.